Meant Health Expands Telehealth for GLP-1 Prescriptions
Meant Health, a digital health platform, announced it is expanding telehealth access for FDA-approved GLP-1 medications, including Ozempic®.
Manassas, Virginia – Meant Health, a digital health platform connecting patients with licensed clinicians for evaluation, prescriptions, and ongoing care coaching, has expanded its telehealth services to include FDA-approved GLP-1 medications.
The expansion allows patients to access prescriptions for weight management medications, such as Ozempic® and similar drugs, through virtual consultations. The platform facilitates initial patient evaluations and provides continuous care coaching for those undergoing treatment.
This move aims to improve access to these widely used medications, which have demonstrated effectiveness in weight management and type 2 diabetes treatment. Meant Health is responding to a growing demand for remote healthcare services, particularly for specialized prescriptions.
Meant Health stated that all prescriptions are issued by licensed clinicians in accordance with FDA guidelines. The company's initiative reflects an effort to make healthcare more accessible and convenient through digital solutions.